Spots Global Cancer Trial Database for Role of Immunoscore® in Stage II-III Colorectal Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Role of Immunoscore® in Stage II-III Colorectal Cancer
Official Title: Role of Immunoscore® in Stage II-III Colorectal Cancer
Study ID: NCT05422547
Conditions
Interventions
Study Description
Brief Summary: The proposed study is a bidirectional analytical study, composed of a retrospective and a prospective cohorts. Patients with stage II - III colorectal cancer undergoing oncological surgery will be analyzed. The study will include a convenience sample of 100 individuals. Fifty cases will be included retrospectively and fifty prospectively. The study aims to evaluate the benefit of using the Immunoscore test as a predictor of recurrence in patients with operated stage II-III colon tumors. It will also be evaluated the impact on oncologic decision and costs.
Detailed Description:
Eligibility
Minimum Age:
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Instituto D'Or de Pesquisa e Ensino - Brasília, Brasília, Distrito Federal, Brazil
Instituto D'Or de Pesquisa e Ensino - Rio de Janeiro, Rio De Janeiro, , Brazil
Contact Details
Name: Paulo M Hoff, PhD
Affiliation: Instituto D'Or de Pesquisa e Ensino
Role: STUDY_CHAIR
Name: Fernando A Soares, PhD
Affiliation: Instituto D'Or de Pesquisa e Ensino
Role: STUDY_CHAIR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
